Compositions and methods for treating hypercholesterolemia using Ortanique peel extract
- 专利权人:
- Curtis O. Green
- 发明人:
- Curtis O. Green,Helen N. Asemota
- 申请号：
- US13018679
- 公开号：
- US08268369B2
- 申请日:
- 2011.02.01
- 申请国别(地区):
- US
- 年份:
- 2012
- 代理人:
- 摘要：
- The invention relates to compositions and methods for treating hypercholesterolemia, including methods for increasing HDL cholesterol levels, using a composition comprising an extract from the Ortanique peel. The invention also relates to compositions and methods for treating hypercholesterolemia, including methods for increasing HDL cholesterol levels, using a composition comprising substantially similar amounts of tetramethylscutellarein and nobiletin by weight and/or a composition comprising substantially similar amounts of tetramethylscutellarein, nobiletin, and tangeretin by weight.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSITIONS AND METHODS FOR EFFECTING THE LEVELS OF HIGH DENSITY LIPOPROTEIN (HDL) CHOLESTEROL AND APOLIPOPROTEIN AI, VERY LOW DENSITY LIPOPROTEIN (VLDL) CHOLESTEROL AND LOW DENSITY LIPOPROTEIN (LDL) CHOLESTEROL
- Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
- Compositions and methods for effecting the levels of high density lipoprotein (HDL) cholesterol and apolipoprotein AI very low density lipoprotein (VLDL) cholesterol and low density lipoprotein (LDL) cholesterol
- СПОСОБ ИНДИВИДУАЛЬНОЙ ОЦЕНКИ ПРИНАДЛЕЖНОСТИ ПАЦИЕНТОВ К ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ
- Acid Derivatives benzoazepin - Oxy acid as agonists of peroxisome proliferator activated receptor Delta used to increase high density lipoprotein cholesterol, low density lipoprotein, reduce cholesterol and reduce
